Becton Dickinson

CEO Tom Polen has advanced the BD 2025 strategy (grow, simplify, empower), navigated Alaris remediation to FDA clearance, added APM, and pursued the Waters RMT to simplify the portfolio and enhance long-term compounding. Governance and quality systems improved, though the SEC settlement over prior Alaris disclosures is a cautionary reminder.

The recent CFO transition plan introduces temporary uncertainty; an experienced interim CFO has been named while a search is underway. Culturally, BD continues to emphasize U.S. manufacturing investment and supply reliability, which aligns with customer priorities. Overall, we see a competent, execution-focused team with clear capital priorities.